Buscar
Mostrando ítems 1-10 de 74
Concomitant tumor resistance
(Elsevier Ireland, 2012-11)
Concomitant tumor resistance (CR) is a phenomenon in which a tumor-bearing host is resistant to the growth of secondary tumor implants. This phenomenon has been described in human and animal systems and it can be generated ...
The acceleration of metastases after tumor removal and the paradoxical phenomenon of concomitant tumor resistance
(Noble Research, 2018-10)
Although surgical extirpation of tumors is usually clinically recommended, tumor removal may entail an undesired side effect: the risk of accelerating the growth of metastases. This effect may account for the relatively ...
Revisiting the phenomenon of concomitant tumor resistance and its impact on established metastases of murine and human origin
(Global Advanced Research Journals, 2017-12)
Concomitant tumor resistance (CR) is a phenomenon in which a tumor-bearing host inhibits the growthofsecondary tumor implants. The relevance of CR to mechanisms of metastases control has been highlightedby numerous ...
Tyrosine isomers mediate the classical phenomenon of concomitant tumor resistance
(American Association for Cancer Research, 2011-11)
Concomitant tumor resistance (CR) is a phenomenon originally described in 1906 in which a tumor-bearing host is resistant to the growth of secondary tumor implants and metastasis. Although recent studies have indicated ...
Concomitant tumor resistance: The role of tyrosine isomers in the mechanisms of metastases control
(American Association for Cancer Research, 2012-03)
Concomitant tumor resistance (CR) is a phenomenon in which a tumor-bearing host is resistant to the growth of secondary tumor implants and metastasis. Although previous studies indicated that T-cell-dependent processes ...
Metformin reduces the stimulatory effect of obesity on in vivo Walker-256 tumor development and increases the area of tumor necrosis
(PERGAMON-ELSEVIER SCIENCE LTD, 2011)
Aims: The objective of this study was to analyze the influence of obesity and insulin resistance on tumor development and, in turn, the effect of insulin sensitizing agents. Main methods: Male offspring of Wistar rats ...
Game-changing restraint of Ros-damaged phenylalanine, upon tumor metastasis article
(Nature, 2018-02)
An abrupt increase in metastatic growth as a consequence of the removal of primary tumors suggests that the concomitant resistance (CR) phenomenon might occur in human cancer. CR occurs in murine tumors and ROS-damaged ...
Chlorella vulgaris Modulates Immunomyelopoietic Activity and Enhances the Resistance of Tumor-Bearing Mice
(Lawrence Erlbaum Assoc Inc-taylor & FrancisPhiladelphiaEUA, 2010)
Prior and concomitant dehydroepiandrosterone treatment affects immunologic response of cultured macrophages infected with Trypanosoma cruzi in vitro?
(ELSEVIER SCIENCE BV, 2011)
DHEA, a steroid hormone synthesized from cholesterol by cells of the adrenal cortex, plays an essential role in enhancing the host`s resistance to different experimental infections. Receptors for this hormone can be found ...